参考文献
[1]中华医学会心血管病学分会介入心脏病学组，中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南（2012）.中华心血管病杂志，2012，40：271-277.
[2]乔树宾，戴军，胡奉环，等.心血管介入治疗高级培训教程.北京：人民卫生出版社，2011：149-159.
[3]Wijns W,et al.Guidelines on myocardial revascularization.Task Force on Myocardial Revascularization of the EuropeanSociety of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS),European Association for Percutaneous Cardiovascular Interventions(EAPCI).Eur Heart J,2010,31:2501-2555.
[4]Levine GN,Bates ER,Blankenship JC,et al.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions.Circulation,2011,124:e574-651.
[5]Hillis LD,Smith PK,Anderson JL,et al.2011 ACCF/AHA guideline for coronary artery bypass graft surgery.A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.developed in collaboration with the American Association for Thoracic Surgery,Society of Cardiovascular Anesthesiologists,and Society of Thoracic Surgeons.J Am Coll Cardiol,2011,58:e123-210.
[6]Jneid H,Anderson JN,Wright RS,et al.2012 ACCF/AHA forced update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction(updating the 2007 guidelines and replacing the 2011 focused update):a report of the American College of Cardiology Foundation/American Heart Asociation Task Force on Practice Guidelines.J Am Coll Cardiol,2012,60:645-681.
[7]Bertrand OF,Bélisle P,Joyal D,et al.Comparison of transradial and femoral approaches for percutaneous coronary interventions:a systematic review and hierarchical Bayesian meta-analysis.Am Heart J,2012,163:632-648.
[8]Rognoni A,Lupi A,Sansa M,et al.Radial approach for percutaneous coronary intervention.Rev Recent Clin Trials,2012,7:127-132.(https://www.daowen.com)
[9]Brilakis ES,Aaron-Grantham J,Stéphane R,et al.A percutaneous treatment algorithm for crossing coronary chronic total occlusions.J Am Coll Cardiol Intv,2012,5:367-379.
[10]Morino Y,Kimura T,Hayashi Y,et al.In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry(Multicenter CTO Registry in Japan).J Am Coll Cardiol Intv,2010,3:143-151.
[11]Joyal D,Thompson CA,Grantham JA,et al.The retrograde technique for recanalization of chronic total occlusions:a step-by-step approach.J Am Coll Cardiol Intv,2012,5:1-11.
[12]Brilakis ES,Grantham JA,Thompson CA,et al.The retrograde approach to coronary artery chronic total occlusions:a practical approach.Catheter Cardiovasc Interv,2012,79:3-19.
[13]Mehran R,Rao SV,Bhatt DL,et al.Standardized bleeding definitions for cardiovascular clinical trials:a consensus report from the Bleeding Academic Research Consortium.Circulation,2011,123:2736-2747.
[14]Abraham NS,Kahi CJ.ACCF/AHA/ACG 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines:a focused update of the ACCF/AHA/ACG 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.JACC,2010,56:2051-2066.
[15]Shaun G,Goodman MD,Robert-Clare MS,et al.Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor insights from the platelet inhibition and patient outcomes trial.Circulation,2012,125:978-986.